Pediatric response to second-line antiretroviral therapy in South Africa
about
Sequencing paediatric antiretroviral therapy in the context of a public health approachClinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in ZimbabweGetting to 90-90-90 in paediatric HIV: What is needed?Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling studyVirologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South AfricaCost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in AsiaOutcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study[Treatment failure in children infected with HIV in routine follow-up in a resource-limited setting in Cameroon]Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy.Tackling virological failure in HIV-infected children living in Africa.Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.Higher retention and viral suppression with adolescent-focused HIV clinic in South AfricaTime to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand
P2860
Q26774261-E6D14FE2-20F3-4B05-B4F2-C3A6D18185B1Q28551494-BC2294FD-0BE7-4C24-9547-B82E6E7CCB72Q30385352-0F95A10F-F7A0-4B3A-BEF4-E36447228189Q34508454-2B764D1F-514E-4792-A330-98B35EBFDA92Q35156697-A6A87881-DB01-45D3-A114-C2E4DF81077EQ35955127-6C9FBA5D-F963-4A82-80CB-756E1354BC1DQ36063912-5DBEA075-7F12-4B6D-AE9A-317F314AAC43Q36087922-661C872C-1E8A-4AE6-9342-310E3A23F712Q37260613-4335E556-5861-4D2E-9778-1C47EA89FEE2Q37722675-37A6C204-ACE3-40FE-9272-A33BC527E7AFQ38552894-95353F92-559A-4E0D-BE69-6661E39D8B94Q41071212-82443314-1F1E-4F39-A842-CF41A86B6A37Q41929466-448CD37F-A607-460B-8EAE-716CF224EB89Q47008725-829B87DD-D24E-43E3-9898-66CDC5392D5CQ57077691-60BE1F67-32E2-4D11-8CA9-63F2AF30FB95
P2860
Pediatric response to second-line antiretroviral therapy in South Africa
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pediatric response to second-line antiretroviral therapy in South Africa
@ast
Pediatric response to second-line antiretroviral therapy in South Africa
@en
Pediatric response to second-line antiretroviral therapy in South Africa
@nl
type
label
Pediatric response to second-line antiretroviral therapy in South Africa
@ast
Pediatric response to second-line antiretroviral therapy in South Africa
@en
Pediatric response to second-line antiretroviral therapy in South Africa
@nl
prefLabel
Pediatric response to second-line antiretroviral therapy in South Africa
@ast
Pediatric response to second-line antiretroviral therapy in South Africa
@en
Pediatric response to second-line antiretroviral therapy in South Africa
@nl
P2093
P2860
P1433
P1476
Pediatric response to second-line antiretroviral therapy in South Africa
@en
P2093
Brian C Zanoni
Henry Sunpath
Margaret E Feeney
P2860
P304
P356
10.1371/JOURNAL.PONE.0049591
P407
P577
2012-11-20T00:00:00Z